Example: stock market

10 May 2018 Chair: Raanan Shamir 10:00 State-of-the-Art ...

Programmesubject to change. Status as of March 201810 May 2018 09:30 10:00 GastroenterologyState-of-the-Art LectureChair: RaananShamir Hoxgenes in GastroenterologyDenis Duboule(Switzerland)10 May 2018 12:00 12:30 GastroenterologyGastroentologyKeynoteCha ir: Nikhil ThaparUnravelling the commonest GI disorders: a moving storyCarlo Di Lorenzo(USA)Programmesubject to change. Status as of March 201810 May 201814:30 16:30 GastroenterologyCoeliac disease: Diagnosis and Risk factorsChairs: Luisa Mearin, Riccardo Troncone14:30 14:3850 years of Coeliac Disease in ESPGHANS alvatore Auricchio(Italy)14:38 15:01 Environmental risk factorsStefano Guandalini(USA) 15:01 15:11 Abstract: Non-invasive biomarkers for assessment of villous abnormalities in patients with coeliac disease and other entero

Programme subject to change. Status as of March 2018 10 May 2018 14:30 –16:30 Nutrition Nutrition in critical illness Chairs: Jessie Hulst, Nick Embleton

Tags:

  Nutrition, Nutrition nutrition

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of 10 May 2018 Chair: Raanan Shamir 10:00 State-of-the-Art ...

1 Programmesubject to change. Status as of March 201810 May 2018 09:30 10:00 GastroenterologyState-of-the-Art LectureChair: RaananShamir Hoxgenes in GastroenterologyDenis Duboule(Switzerland)10 May 2018 12:00 12:30 GastroenterologyGastroentologyKeynoteCha ir: Nikhil ThaparUnravelling the commonest GI disorders: a moving storyCarlo Di Lorenzo(USA)Programmesubject to change. Status as of March 201810 May 201814:30 16:30 GastroenterologyCoeliac disease: Diagnosis and Risk factorsChairs: Luisa Mearin, Riccardo Troncone14:30 14:3850 years of Coeliac Disease in ESPGHANS alvatore Auricchio(Italy)14:38 15:01 Environmental risk factorsStefano Guandalini(USA) 15:01 15:11 Abstract: Non-invasive biomarkers for assessment of villous abnormalities in patients with coeliac disease and other enteropathies: An alternative to mucosal biopsiesAlkaSingh (India)15:11 15.

2 34 Genetics,beyondHLAIris Jonkers(The Netherlands)15:34 15:44 Abstract:ESPGHAN non-biopsycriteriahave100% accuracyforceliacdisease: a prospectivemulticenterstudyapplyingstand ardizedduodenal morphometryAlina Popp(Romania)15:44 16:07 Methodological developments in diagnosisIlmaKorponay-Szabo(Hungary)16:0 7 16:30 New revision of GuidelinesSteffen Husby(Denmark)Programmesubject to change. Status as of March 201810 May201814:30 16:30 NutritionNutrition in critical illnessChairs: Jessie Hulst, Nick Embleton14:30 15:00 Acute stress response: when to feed in critical illnessUrban Fl ring(Sweden) 15:00 -15:10 Abstract: Body composition in preterm infants: changes over time and effect of nutrition in the early neonatal period (PeaPodstudy)Anna Chmielewska(Sweden)15:10 15:40 Macronutrients in the critically ill childGreet van den Berghe(Belgium)15:40 15:50 Abstract.

3 nutrition and growth outcomes of children on enteral nutrition support completing an intensive weaning programTal Sadeh-Kon(Israel)15:50 16:00 Abstract: Body composition and growth in children with intestinal failure receiving long-term parenteral nutritionEsther Neelis(Netherlands)16:00 16:30 nutrition after acute birth asphyxia Boubou Hallberg(Sweden)Programmesubject to change. Status as of March 201810 May 201814:30 16:30 HepatologyCongenitalporto-systemicshunti ngChairs: Yael Moser, Fran oiseSmets14:30 15:03 Challengesin diagnosingandtreatingCPSSE lchananBruckheimer(Israel)15:03 15:13 Abstract: Infantile hepatic haemangioendothelioma: clinical features and predictors of outcome in a large cohort of patientsLorenzo D Antiga(Italy)15:13 15:46 Natural history of CPPS including encephalopathy Val rieMcLin(Switzerland)15:46 16.

4 19 Who is candidate for surgical and/or endovascular interventions for CPPS St phanieFranchi-Abella(France)16:19 16:29 Abstract: Liver disease related to alpha1-antitrypsin deficiency in French children: the DEFI-ALPHA cohortMathias Ruiz (France)Programmesubject to change. Status as of March 201810 May 201814:30 16:30 GastroenterologyHelicobacter pylori: achieving high quality careChairs: MatjazHoman, Dominique Belli14:30 14:40 Helicobacter Pylori and ESPGHANSamyCadranel(Belgium)14:40 15:10 The gastric microbiotain health and diseaseTeresa Alarcon(Spain)15:10 15:40 Helicobacter pylori infection and cancer: implications for care in children?

5 Francis M graud(France)15:40 16:10 Implications of current knowledge to improve pediatric careSibylleKoletzko(Germany)16:10 16:20 Abstract: Bovine lactoferrinin the prevention of antibiotic-associated diarrhoeain children: a randomisedclinical trialMichal Filip Wronowski(Poland)16:20 16:30 Abstract:Human leukocyte antigen class II alleles and outcome of giardiasis in children: is there a link?Ahmed Megahed(Egypt)Programmesubject to change. Status as of March 201810 May 201817:00 18:00 HepatologyParallel Session 1 -AbstractsChairs: Tassos Grammatikopoulos, Loreto Hierro17:00 17:10 Clinicopathologicalstudy in 80 patients with Biliary atresia treated by liver transplantation with and without prior Kasai portoenterostomyNora Vanderheyden(Belgium)17:10 17:20 Serum concentration of ceramides in obese children with nonalcoholic fatty liver diseaseNatalia Wasilewska(Poland)17:20 17.

6 30A metabolomicsalivary signature of pediatric obesity related liver Pierri(Italy)17:30 17:40 Biliatresone, a toxic model of biliary atresia in animals, causes damage to extrahepatic bile ducts, and its toxicity is related to decrease in GSHO rithWaisbourd-Zinman(Israel)17:40 17:50 MicroRNA-29a mitigation of toll like receptor 2 and 4 signaling and alleviation obstructive jaundice-induced fibrosis in miceYa-Ling Yang (Taiwan)17:50 18:00 The correlation between histopathologic steatosis/fibrosis and various non-invasive imaging and blood fibrosis indicators of overweight and obese childrenBilge Sahin Akkelle(Turkey)Programmesubject to change.

7 Status as of March 201810 May201817:00 18:00 nutrition Parallel Session1 -AbstractsChairs: Alexandre Lapillonne, Laetitia-Marie Petit17:00 17:10 Longitudinal analysis of butyrate in human milk: a GEHM study of three global cohorts through the first year of lactationSarah D. Maria (United States)17:10 17:20 Longitudinal evolution of major protein concentration in preterm and term human milkClara L. Garcia Rodenas(Switzerland)17:20 17:30 Osteopontin levels in human milk vary across countries and within lactation period: Data from a multicenter studySigne Bruun(Denmark)17:30 17:40 Body composition of infants fed goat-milk infant formula vs.

8 Cow-milk infant formula: a randomisedcontrolled trialShaoJiaZhou (Australia)17:40 17:50A partlyfermentedinfantformulawithprebioti csscGOS/lcFOSmodulatesthegut microbiotafunctioningtowardsa morebreastfed-like microbiotaSebastian Tims (Netherlands)17:50 18:00 Maturational effects on sleep/wake patterns in infants receiving a cow s milk-based infant formula with a prebiotic blendJohn Colombo (United States)Programmesubject to change. Status as of March 201810 May 201817:00 18:00 Clinical Track in HepatologyClinical TrackChairs: Piotr Socha, GiorginaMieli-Vergani17:00 17:30 Wilson sdiseasePiotr Socha (Poland)17:30 18:00 AutoimmunityandliverdiseaseGiorginaMieli -Vergani(UK)Programmesubject to change.

9 Status as of March 201810 May 201817:00 18:00 GastroenterologyParallel Session 1 -AbstractsChairs: Raoul Furlano, Genevieve Veereman17:00 17:10 Phenotype, genetics and outcomes in an infantile-onset IBD cohortRaffi Lev-Tzion(Israel)17:10 17:20 VEO-IBD consortium: interim report on genetic analysis of 480 patients and discovery of biallelicTGFB1 deficiencyDaniel Kotlarz(Germany)17:20 17:30 Activatedphosphoinositide3-kinase syndromecausessevereintestinal lLympho-nodularhyperplasiaandan IBD-like phenotypeDrorShouval(Israel)17:30 17:40 Functional clustering of paediatricIBD patients: hypo-inflammatory immune signatures of innate signallingin a treatment na ve cohortTracy Coelho (United Kingdom)17:40 17:50 Differences in therapeutic approaches and outcomes in paediatricand adult onset Crohn`s disease with Perianal fistula (CD-PAF).

10 Comparison of 2 multicentrefistula cohortsRaj Singh Parmar (United Kingdom)17:50 18:00 Incidence and prevalence of UC, CD and their rare and severe complications; the first pan-European paediatricIBD database PolychronisKemos(Greece)Programmesubject to change. Status as of March 201810 May 201817:00 18:00 GastroenterologyParallel Session 2 -AbstractsChairs: Matthias Zilbauer17:00 17:10 The gut microbiota composition and metabolic activity of HLA-B27 transgenic rats with gut inflammation resembles the dysbioticcharacteristics of human inflammatory bowel diseaseVaios Svolos(United Kingdom)17:10 17:20 Zinc finger transcription factor ZNF281: a novel promoter of intestinal fibrosis?


Related search queries